Spring bank pharmaceuticals, inc. (SBPH)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Dec'14
ASSETS
Current assets:
Cash and cash equivalents

30,633

28,709

34,371

10,547

16,750

14,724

23,637

13,109

23,838

23,649

17,539

51,443

14,038

10,684

5,332

11,326

1,903

4,347

1,570

Escrow receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,562

Marketable securities

16,873

25,746

28,778

38,646

29,857

32,914

29,868

26,846

23,321

26,906

34,640

4,936

7,062

14,046

10,313

8,289

4,875

5,335

-

Prepaid expenses and other current assets

2,961

3,522

1,727

2,402

1,218

1,649

1,029

1,205

609

580

850

884

481

840

1,059

1,039

426

313

547

Total current assets

50,467

57,977

64,876

51,595

47,825

49,287

54,534

41,160

47,768

51,135

53,029

57,263

21,581

25,570

16,704

20,654

7,204

9,995

13,679

Marketable securities, long-term

-

-

-

-

10,873

16,804

17,827

-

-

-

-

-

-

752

-

-

1,386

3,189

-

Property and equipment, net

2,140

2,234

2,264

2,353

2,307

2,319

2,391

1,579

892

687

534

550

586

522

496

523

498

427

126

Operating lease right-of-use assets

2,648

2,717

2,784

2,850

2,915

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

234

234

234

234

234

234

234

234

234

484

250

-

-

-

-

-

-

-

-

Other assets

35

35

35

35

198

167

81

35

216

35

35

35

35

35

35

-

1,690

966

-

Total

55,524

63,197

70,193

57,067

64,352

68,811

75,067

43,008

49,110

52,341

53,848

57,848

22,202

26,879

17,235

21,177

10,778

14,577

13,805

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

1,992

2,210

2,986

1,725

1,986

1,880

1,374

1,688

1,655

1,700

1,773

1,802

1,921

1,519

2,340

2,858

1,343

2,183

348

Accrued expenses and other current liabilities

2,486

2,438

1,998

3,185

1,693

2,367

3,740

2,587

2,130

2,734

2,312

1,742

894

1,982

1,360

1,087

1,829

1,363

1,257

Convertible term loan, net of unamortized discount

19,147

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest payable

399

403

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, current

367

355

343

332

269

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

24,391

5,406

5,327

5,242

3,948

4,247

5,114

4,275

3,785

4,434

4,085

3,544

2,815

3,501

3,700

3,945

3,172

3,546

1,605

Convertible term loan, net of unamortized discount

-

19,070

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible term loan, net of unamortized discount

-

-

19,011

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liabilities

60

299

450

805

5,690

8,511

9,291

7,955

11,926

13,128

17,807

12,027

8,360

6,333

-

-

-

-

-

Operating lease liabilities, noncurrent

2,774

2,869

2,962

3,052

3,141

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

27

27

27

27

27

193

130

121

30

31

32

33

34

27

-

-

-

6

-

Total liabilities

27,252

27,671

27,777

9,126

12,806

12,951

14,535

12,351

15,741

17,593

21,924

15,604

11,209

9,861

-

-

-

3,552

-

Commitments and contingencies (Note 11)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Preferred stock, $0.0001 par value—authorized, 10,000,000 shares at March 31, 2020 and December 31, 2019; no shares issued or outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

-

Common stock, $0.0001 par value—authorized, 200,000,000 shares at March 31, 2020 and December 31, 2019; 16,582,444 and 16,513,763 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

-

Additional paid-in capital

162,771

161,924

161,382

159,975

158,928

157,931

157,209

118,541

117,469

113,984

109,682

109,170

69,031

68,559

62,669

62,216

48,293

45,211

34,805

Accumulated deficit

-134,343

-126,165

-118,730

-111,818

-107,263

-102,068

-96,643

-87,863

-84,101

-79,214

-77,752

-66,924

-58,035

-51,535

-49,135

-44,988

-40,687

-34,169

-22,605

Accumulated other comprehensive loss

-158

-235

-238

-218

-121

-5

-36

-22

-

-23

-7

-3

-4

-7

-

3

-1

-18

-

Total stockholders’ equity

28,272

35,526

42,416

47,941

51,546

55,860

60,532

30,657

33,369

34,748

31,924

42,244

10,993

17,018

13,535

17,232

7,606

11,025

12,200

Total

55,524

63,197

70,193

57,067

64,352

68,811

75,067

43,008

49,110

52,341

53,848

57,848

22,202

26,879

17,235

21,177

10,778

14,577

13,805